Based on our data that IL-2 and IL-33 by themselves increased Tregs and partially protected from IRI and that these cytokines synergize to completely protect from AKI, we generated a novel hybrid cytokine (termed IL233) bearing activities of IL-2 and IL-33 in a single molecule (169). Here, IL33 is linked to acute kidney injury.